Ask your AI about this

Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:

Connect your AI · Plans and the 7-day free trial (card required)

Holdings, Q3 2026

Largest first. Common shares only.

Latest 13F holdings
#The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here.Filing
1ARGX
argenx SE · ADR
181,500$174.0M39.3%+38.3%13F ↗
2RYTM
Rhythm Pharmaceuticals, Inc.
1.22M$115.8M26.2%+2.6%13F ↗
3RVMD
Revolution Medicines, Inc.
422,911$86.8M19.6%+3.1%13F ↗
4CYTK
Cytokinetics, Incorporated
517,278$34.1M7.7%+8.9%13F ↗
5IRON
Disc Medicine, Inc.
399,830$26.2M5.9%+66.5%13F ↗
6SEPN
Septerna, Inc.
64,000$2.5M0.6%New13F ↗
7TRVI
Trevi Therapeutics, Inc.
137,000$2.0M0.4%+82.7%13F ↗
8OCS
Oculis Holding AG
99,500$929.3K0.2%New13F ↗

Changes since Q2 2026

2 new, 6 added to, 0 trimmed, 0 exited, 0 unchanged. By estimated dollars.

New positions (2)

New positions
SEPN
Septerna, Inc.
64,000New$2.5M
OCS
Oculis Holding AG
99,500New$929.3K

Added to (6)

Added to
ARGX
argenx SE · ADR
181,500+38.3%$48.2M
IRON
Disc Medicine, Inc.
399,830+66.5%$10.5M
RYTM
Rhythm Pharmaceuticals, Inc.
1.22M+2.6%$2.9M
CYTK
Cytokinetics, Incorporated
517,278+8.9%$2.8M
RVMD
Revolution Medicines, Inc.
422,911+3.1%$2.6M
TRVI
Trevi Therapeutics, Inc.
137,000+82.7%$887.8K

Trimmed (0)

None this quarter.

Exited (0)

None this quarter.

The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.

Compare two quarters

Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.

Reported value by quarter

Value and number of positions at the end of each quarter.

Loading…

Largest positions in earlier quarters

Pick a quarter to see what the fund's biggest positions were then.

Loading…

Ten largest positions

By value, Q3 2026.

$0$50.0M$100.0M$150.0M$200.0MARGX · Value: $174,042,165ARGXRYTM · Value: $115,836,093RYTMRVMD · Value: $86,806,712RVMDCYTK · Value: $34,093,793CYTKIRON · Value: $26,172,872IRONSEPN · Value: $2,504,320SEPNTRVI · Value: $1,961,840TRVIOCS · Value: $929,330OCS

Filings

13F filings
Filing
Q3 2026Nov 13, 202613F-HR8$442.3MCurrentSEC ↗
Q2 2026Aug 14, 202613F-HR6$389.8MCurrentSEC ↗
Q1 2026May 15, 202613F-HR8$278.7MCurrentSEC ↗
Q4 2025Feb 17, 202613F-HR7$320.1MCurrentSEC ↗
Q3 2025Nov 14, 202513F-HR10$298.5MCurrentSEC ↗
Q2 2025Aug 14, 202513F-HR8$214.6MCurrentSEC ↗
Q1 2025May 15, 202513F-HR14$182.3MCurrentSEC ↗

Most recent first, up to 80. An amendment can replace a report or add holdings to it. All 13F filings

Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer